Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Head and Neck Cancers
•
Radiation Oncology
•
Melanoma/Skin Cancer
•
Medical Oncology
What is your approach to treating inoperable mucosal melanoma of the head and neck region?
What is the preferred dose, fractionation, and role of concurrent chemo?
Answer from: Radiation Oncologist at Academic Institution
It is often nasal cavity/paranasal sinuses, so 1.2 Gy BID to 74.4 Gy and electively treat the neck. Otherwise 70 Gy/35 fx/30 treatment days SIB.
Comments
Radiation Oncologist at The Toledo Clinic
Do you treat only the ipsilateral neck?
Radiation Oncologist at University of Florida
I would treat the ipsilateral neck electively.
Radiation Oncologist at The Toledo Clinic
Thank you.
Radiation Oncologist at Providence St. Mary Medical Center
Role for immunotherapy? Neoadj or Adj?
10987
10991
10993
14435
Sign In
or
Register
to read more
675
Related Questions
What are your top takeaways in Head & Neck Cancers from ASCO 2025?
Would you consider neoadjuvant immunotherapy prior to radiation for a locally advanced skin squamous cell carcinoma?
How do you counsel patients regarding alcohol consumption following treatment of head and neck cancer?
How would you apply the results of CheckMate 204 in an asymptomatic patient with 10-20 metastatic brain lesions on dual immunotherapy for melanoma?
How would you approach a patient with a carotid body tumor and metastasis to the cervical lymph node?
How would you approach management of a large, fungating squamous cell carcinoma of the auricle if surgical management is not desired by the patient?
If adjuvant radiation is offered to an elderly patient with H&N SCC s/p Mohs surgery who is planned for multi-stage reconstruction of the defect with plastic surgery, when should adjuvant radiation be started?
In what situations would you recommend adjuvant radiation therapy for patients with locally advanced and/or recurrent basal cell carcinoma that receive vismodegib followed by surgery?
How would the updated results of ECOG 3311 influence your adjuvant RT recommendations for HPV+ OPSCC?
When would you offer neoadjuvant immunotherapy prior to Mohs surgery in a locally advanced squamous cell carcinoma for which clearance may require enucleation?
Do you treat only the ipsilateral neck?
I would treat the ipsilateral neck electively.
Thank you.
Role for immunotherapy? Neoadj or Adj?